{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:04:28Z","timestamp":1788887068813,"version":"build-2803163510"},"reference-count":89,"publisher":"Bentham Science Publishers Ltd.","issue":"17","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Epilepsy is one of the most common in all age groups and disabling\nneurologic disorders around the world.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>This systematic review was to explore whether berberine (BBR) has any anti-seizure\nor anti-epileptic effects and also reviewed this possible mechanism.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The EMBASE, Scopus, Cochrane Library, PubMed, and Web of Science databases\nwere searched before Sep 2023. All types of studies that investigated the effects of BBR on epilepsy\nor chemical-induced seizures were eligible for inclusion. Two authors independently evaluated\nand reviewed titles\/abstracts to identify publications for potential eligibility, and a third\nteam member resolved discrepancies. Data were extracted in an Excel form, and the outcomes\nwere discussed.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>BBR showed its neuroprotective properties by reducing oxidative stress, neuroinflammation,\nand anti-apoptosis effects. It also increases brain-derived neurotrophic factor (BDNF)\nrelease and reduces transforming growth factor-beta (TGF-\u03b21) and hypoxia-inducible factor 1\u03b1\n(HIF-1\u03b1). BBR by increasing scavenging reactive oxygen species (ROS), nuclear factor\nerythroid 2\u2013related factor 2 (Nrf2), endogenous antioxidant enzymes, heme oxygenase-1 (HO-1),\nand inhibition of lipid peroxidation insert its antioxidant activity. Moreover, BBR showed antiinflammatory\nactivity by reducing Interleukin (IL)-1\u03b2, IL-6, and tumor necrosis factor-alpha\n(TNF-\u03b1) levels and through inhibiting cyclooxygenase-2 (COX-2), and including nuclear factor\n\u03baB (NF-\u03baB). In addition, it modulated c-fos expression and neuronal excitability in the brain.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>BBR indicated promising anti-seizure effects with remarkable antioxidant, antiinflammatory,\nanti-apoptotic, and neuroprotective activity. Future studies should be based on\nwell-designed clinical trial studies that are integrated with new methods related to increasing\nbioavailability.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0113892010283237240107121749","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T12:00:14Z","timestamp":1708603214000},"page":"2253-2265","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Anti-seizure Effects and Mechanisms of Berberine: A Systematic Review"],"prefix":"10.2174","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6735-9577","authenticated-orcid":true,"given":"Nahid","family":"Jivad","sequence":"first","affiliation":[{"name":"Department of Neurology, School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7592-3868","authenticated-orcid":true,"given":"Saeid","family":"Heidari-Soureshjani","sequence":"additional","affiliation":[{"name":"Modeling in Health Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8457-8633","authenticated-orcid":true,"given":"Hesamaldin","family":"Bagheri","sequence":"additional","affiliation":[{"name":"Medical Plants\nResearch Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0844-3207","authenticated-orcid":true,"given":"Catherine M.T.","family":"Sherwin","sequence":"additional","affiliation":[{"name":"Professor and Vice-Chair for Research, Pediatric Clinical Pharmacology and Toxicology, Department of Pediatrics,\nWright State University Boonshoft School of Medicine, Dayton Children's Hospital, One Children's Plaza, Dayton,\nOhio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4182-6004","authenticated-orcid":true,"given":"Sahar","family":"Rostamian","sequence":"additional","affiliation":[{"name":"Department of Medicine, Harvard\nMedical School, Boston, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000503831","volume":"54","author":"Beghi E.","year":"2020","unstructured":"Beghi E.; The epidemiology of epilepsy. Neuroepidemiology  2020,54(2),185-191","journal-title":"Neuroepidemiology"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"a022426","DOI":"10.1101\/cshperspect.a022426","volume":"5","author":"Stafstrom C.E.","year":"2015","unstructured":"Stafstrom C.E.; Carmant L.; Seizures and epilepsy: An overview for neuroscientists. Cold Spring Harb Perspect Med  2015,5(6),a022426","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.15190\/d.2020.7","volume":"8","author":"Anwar H.","year":"2020","unstructured":"Anwar H.; Khan Q.U.; Nadeem N.; Pervaiz I.; Ali M.; Cheema F.F.; Epileptic seizures. Discoveries  2020,8(2),e110","journal-title":"Discoveries"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1002\/epi4.12581","volume":"7","author":"Talevi A.","year":"2022","unstructured":"Talevi A.; Antiseizure medication discovery: Recent and future paradigm shifts. Epilepsia Open  2022,7(S1),S133-S141","journal-title":"Epilepsia Open"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"e35045","DOI":"10.7759\/cureus.35045","volume":"15","author":"Kalra S.","year":"2023","unstructured":"Kalra S.; Jiwan T.; Singh G.; Gautam P.L.; Bansal A.; A comparison of the quality of life of people with epilepsy receiving home-based and clinic-based epilepsy care using the european quality of life five-dimension three-level (EQ-5D-3L) scale. Cureus  2023,15(2),e35045","journal-title":"Cureus"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.3390\/ijms22084061","volume":"22","author":"Espinosa-Garcia C.","year":"2021","unstructured":"Espinosa-Garcia C.; Zeleke H.; Rojas A.; Impact of stress on epilepsy: Focus on neuroinflammation\u2014a mini review. Int J Mol Sci  2021,22(8),4061","journal-title":"Int J Mol Sci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"762654","DOI":"10.3389\/fphar.2021.762654","volume":"12","author":"Ai X.","year":"2021","unstructured":"Ai X.; Yu P.; Peng L.; Luo L.; Liu J.; Li S.; Lai X.; Luan F.; Meng X.; Berberine: A review of its pharmacokinetics properties and therapeutic potentials in diverse vascular diseases. Front Pharmacol  2021,12,762654","journal-title":"Front Pharmacol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"11795735231209209","DOI":"10.1177\/11795735231209209","volume":"15","author":"Gunasekera C.L.","year":"2023","unstructured":"Gunasekera C.L.; Sirven J.I.; Feyissa A.M.; The evolution of antiseizure medication therapy selection in adults: Is artificial intelligence -assisted antiseizure medication selection ready for prime time? J Cent Nerv Syst Dis  2023,15,11795735231209209","journal-title":"J Cent Nerv Syst Dis"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1212\/CON.0000000000001104","volume":"28","author":"Abou-Khalil B.W.","year":"2022","unstructured":"Abou-Khalil B.W.; Update on antiseizure medications 2022. Continuum  2022,28(2),500-535","journal-title":"Continuum"},{"key":"ref=10","first-page":"467","volume":"12","author":"Sarma A.K.","year":"2016","unstructured":"Sarma A.K.; Khandker N.; Kurczewski L.; Brophy G.M.; Medical management of epileptic seizures: Challenges and solutions. Neuropsychiatr Dis Treat  2016,12,467-485","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.34172\/jhp.2023.19","volume":"12","author":"Khaledifar A.","year":"2023","unstructured":"Khaledifar A.; Khosravi Farsani M.R.; Raeisi E.; Berberine efficacy against Doxorubicin-induced cardiotoxicity: A systematic review. J HerbMed Pharmacol  2023,12(2),187-193","journal-title":"J HerbMed Pharmacol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"e1749","DOI":"10.31661\/gmj.v9i0.1749","volume":"9","author":"Amini Chermahini F.","year":"2020","unstructured":"Amini Chermahini F.; Raeisi E.; Aazami M.H.; Mirzaei A.; Heidarian E.; Lemoigne Y.; Does, bromelain-cisplatin combination afford in-vitro synergistic anticancer effects on human prostatic carcinoma cell line PC3? Galen Med J  2020,9,e1749","journal-title":"Galen Med J"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fphar.2013.00177","volume":"4","author":"Ekor M.","year":"2014","unstructured":"Ekor M.; The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol  2014,4,177","journal-title":"Front Pharmacol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.3390\/molecules27123705","volume":"27","author":"Behl T.","year":"2022","unstructured":"Behl T.; Singh S.; Sharma N.; Zahoor I.; Albarrati A.; Albratty M.; Meraya A.M.; Najmi A.; Bungau S.; Expatiating the pharmacological and nanotechnological aspects of the alkaloidal drug berberine: Current and future trends. Molecules  2022,27(12),3705","journal-title":"Molecules"},{"key":"ref=15","unstructured":"Berberine. 2004. Available from:\n https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Berberine"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3390\/toxins12110713","volume":"12","author":"Och A.","year":"2020","unstructured":"Och A.; Podg\u00f3rski R.; Nowak R.; Biological activity of berberine\u2014a summary update. Toxins  2020,12(11),713","journal-title":"Toxins"},{"key":"ref=17","first-page":"538","volume":"20","author":"Mohammadzadeh N.","year":"2017","unstructured":"Mohammadzadeh N.; Mehri S.; Hosseinzadeh H.; Berberis vulgaris and its constituent berberine as antidotes and protective agents against natural or chemical toxicities. Iran J Basic Med Sci  2017,20(5),538-551","journal-title":"Iran J Basic Med Sci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.7150\/thno.30787","volume":"9","author":"Feng X.","year":"2019","unstructured":"Feng X.; Sureda A.; Jafari S.; Memariani Z.; Tewari D.; Annunziata G.; Barrea L.; Hassan S.T.S.; \u0160mejkal K.; Malan\u00edk M.; Sychrov\u00e1 A.; Barreca D.; Ziberna L.; Mahomoodally M.F.; Zengin G.; Xu S.; Nabavi S.M.; Shen A.Z.; Berberine in cardiovascular and metabolic diseases: From mechanisms to therapeutics. Theranostics  2019,9(7),1923-1951","journal-title":"Theranostics"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.2147\/IDR.S357077","volume":"15","author":"Xia S.","year":"2022","unstructured":"Xia S.; Ma L.; Wang G.; Yang J.; Zhang M.; Wang X.; Su J.; Xie M.; In vitro antimicrobial activity and the mechanism of berberine against methicillin-resistant staphylococcus aureus isolated from bloodstream infection patients. Infect Drug Resist  2022,15,1933-1944","journal-title":"Infect Drug Resist"},{"key":"ref=20","first-page":"580","volume":"51","author":"Zheng Y.M.","year":"2016","unstructured":"Zheng Y.M.; Zhang J.P.; Tang S.; Song D.Q.; [Establish and use of an epilepsy model in larval zebrafish]. Yao Xue Xue Bao  2016,51(4),580-587","journal-title":"Yao Xue Xue Bao"},{"key":"ref=21","first-page":"505","volume":"46","author":"Wang X.L.","year":"1994","unstructured":"Wang X.L.; Jin G.Z.; Zhou T.C.; [On the central inhibition action of tetrahydroberberine without relevance to GABA receptors]. Sheng Li Xue Bao  1994,46(5),505-508","journal-title":"Sheng Li Xue Bao"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jams.2012.07.018","volume":"6","author":"Hosseinzadeh H.","year":"2013","unstructured":"Hosseinzadeh H.; Ramezani M.; Shafaei H.; Taghiabadi E.; Anticonvulsant effect of Berberis integerrima L. root extracts in mice. J Acupunct Meridian Stud  2013,6(1),12-17","journal-title":"J Acupunct Meridian Stud"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3390\/cells9051233","volume":"9","author":"Gawel K.","year":"2020","unstructured":"Gawel K.; Kukula-Koch W.; Nieoczym D.; Stepnik K.; van der Ent W.; Banono N.S.; Tarabasz D.; Turski W.A.; Esguerra C.V.; The influence of palmatine isolated from berberis sibirica radix on pentylenetetrazole-induced seizures in zebrafish. Cells  2020,9(5),1233","journal-title":"Cells"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"bmad073","DOI":"10.1093\/chromsci\/bmad073","author":"El-Nahas A.E.","year":"2023","unstructured":"El-Nahas A.E.; Elbedaiwy H.M.; Helmy M.W.; El-Kamel A.H.; Simultaneous estimation of berberine and piperine in a novel nanoformulation for epilepsy control via HPLC. J Chromatogr Sci  2023,bmad073","journal-title":"J Chromatogr Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.yebeh.2010.03.007","volume":"18","author":"Bhutada P.","year":"2010","unstructured":"Bhutada P.; Mundhada Y.; Bansod K.; Dixit P.; Umathe S.; Mundhada D.; Anticonvulsant activity of berberine, an isoquinoline alkaloid in mice. Epilepsy Behav  2010,18(3),207-210","journal-title":"Epilepsy Behav"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.2147\/NDT.S73210","volume":"10","author":"Gao F.","year":"2014","unstructured":"Gao F.; Gao Y.; Liu Y.; Wang L.; Li Y.; Berberine exerts an anticonvulsant effect and ameliorates memory impairment and oxidative stress in a pilocarpine-induced epilepsy model in the rat. Neuropsychiatr Dis Treat  2014,10,2139-2145","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref=27","first-page":"124","volume":"5","author":"Mojarad T.B.","year":"2014","unstructured":"Mojarad T.B.; Roghani M.; The anticonvulsant and antioxidant effects of berberine in kainate-induced temporal lobe epilepsy in rats. Basic Clin Neurosci  2014,5(2),124-130","journal-title":"Basic Clin Neurosci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"189","DOI":"10.6026\/97320630011189","volume":"11","author":"Mathew S.","year":"2015","unstructured":"Mathew S.; Faheem M.; Al-Malki A.; Kumosani T.A.; Qadri I.; In silico inhibition of GABARAP activity using antiepileptic medicinal derived compounds. Bioinformation  2015,11(4),189-195","journal-title":"Bioinformation"},{"key":"ref=29","first-page":"588","volume":"20","author":"Sadeghnia H.R.","year":"2017","unstructured":"Sadeghnia H.R.; Taji A.R.; Forouzanfar F.; Hosseinzadeh H.; Berberine attenuates convulsing behavior and extracellular glutamate and aspartate changes in 4-aminopyridine treated rats. Iran J Basic Med Sci  2017,20(5),588-593","journal-title":"Iran J Basic Med Sci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.biopha.2016.12.109","volume":"87","author":"Sedaghat R.","year":"2017","unstructured":"Sedaghat R.; Taab Y.; Kiasalari Z.; Afshin-Majd S.; Baluchnejadmojarad T.; Roghani M.; Berberine ameliorates intrahippocampal kainate-induced status epilepticus and consequent epileptogenic process in the rat: Underlying mechanisms. Biomed Pharmacother  2017,87,200-208","journal-title":"Biomed Pharmacother"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.14581\/jer.18011","volume":"8","author":"Guna V.","year":"2018","unstructured":"Guna V.; Saha L.; Bhatia A.; Banerjee D.; Chakrabarti A.; Anti-oxidant and anti-apoptotic effects of berberine in pentylenetetrazole-induced kindling model in rat. J Epilepsy Res  2018,8(2),66-73","journal-title":"J Epilepsy Res"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3389\/fnmol.2018.00378","volume":"11","author":"Zheng Y.M.","year":"2018","unstructured":"Zheng Y.M.; Chen B.; Jiang J.D.; Zhang J.P.; Syntaxin 1B mediates berberine\u2019s roles in epilepsy-like behavior in a pentylenetetrazole-induced seizure zebrafish model. Front Mol Neurosci  2018,11,378","journal-title":"Front Mol Neurosci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"468","DOI":"10.5530\/ijper.53.3.79","volume":"53","author":"Senthilvel C.K.","year":"2019","unstructured":"Senthilvel C.K.; Karuppaiyan K.; Moideen M.M.J.; Development of capsules filled with phenytoin and berberine loaded nanoparticles- a new approach to improve anticonvulsant efficacy. IJPER  2019,53(3),468-479","journal-title":"IJPER"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s11481-019-09902-w","volume":"15","author":"Zhang B.","year":"2020","unstructured":"Zhang B.; Wang L.; Ji X.; Zhang S.; Sik A.; Liu K.; Jin M.; Anti-inflammation associated protective mechanism of berberine and its derivatives on attenuating pentylenetetrazole-induced seizures in zebrafish. J Neuroimmune Pharmacol  2020,15(2),309-325","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"362","DOI":"10.52547\/rbmb.10.3.362","volume":"10","author":"Ghanem H.B.","year":"2021","unstructured":"Ghanem H.B.; Emam M.N.; Ali D.A.M.; Abd-Ellatif R.N.; Impact of berberine on some epigenetic, transcription regulation and inflammatory biomarkers in a mice model of epilepsy. Rep Biochem Mol Biol  2021,10(3),362-372","journal-title":"Rep Biochem Mol Biol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00580-023-03502-0","volume":"32","author":"Asadollah-salmanpour Y.","year":"2023","unstructured":"Asadollah-salmanpour Y.; Hassanpour S.; Vazir B.; Effects of berberine on pentylenetetrazole-induced seizures during estrus cycle in rats. Comp Clin Pathol  2023,32(6),919-924","journal-title":"Comp Clin Pathol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ejpb.2023.04.008","volume":"188","author":"El-Nahas A.E.","year":"2023","unstructured":"El-Nahas A.E.; Elbedaiwy H.M.; Masoud I.M.; Aly R.G.; Helmy M.W.; El-Kamel A.H.; Berberine-loaded zein\/hyaluronic acid composite nanoparticles for efficient brain uptake to alleviate neuro-degeneration in the pilocarpine model of epilepsy. Eur J Pharm Biopharm  2023,188,182-200","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1007\/s11064-023-03967-z","volume":"48","author":"Saha L.","year":"2023","unstructured":"Saha L.; Kumari P.; Rawat K.; Gautam V.; Sandhu A.; Singh N.; Bhatia A.; Bhattacharya S.; Sinha V.R.; Chakrabarti A.; Neuroprotective effect of berberine nanoparticles against seizures in pentylenetetrazole induced kindling model of epileptogenesis: Role of anti-oxidative, anti-inflammatory, and anti-apoptotic mechanisms. Neurochem Res  2023,48(10),3055-3072","journal-title":"Neurochem Res"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"845591","DOI":"10.3389\/fphar.2022.845591","volume":"13","author":"Cheng Z.","year":"2022","unstructured":"Cheng Z.; Kang C.; Che S.; Su J.; Sun Q.; Ge T.; Guo Y.; Lv J.; Sun Z.; Yang W.; Li B.; Li X.; Cui R.; Berberine: A promising treatment for neurodegenerative diseases. Front Pharmacol  2022,13,845591","journal-title":"Front Pharmacol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/B978-0-12-803797-3.00004-7","author":"Sharma A.","year":"2016","unstructured":"Sharma A.; Neuroprotective agents. Advances in Structure and Activity Relationship of Coumarin Derivatives  2016,77-99","journal-title":"Advances in Structure and Activity Relationship of Coumarin Derivatives"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"976953","DOI":"10.3389\/fcell.2022.976953","volume":"10","author":"Fabisiak T.","year":"2022","unstructured":"Fabisiak T.; Patel M.; Crosstalk between neuroinflammation and oxidative stress in epilepsy. Front Cell Dev Biol  2022,10,976953","journal-title":"Front Cell Dev Biol"},{"key":"ref=42","first-page":"594","volume":"20","author":"Sadeghnia H.R.","year":"2017","unstructured":"Sadeghnia H.R.; Kolangikhah M.; Asadpour E.; Forouzanfar F.; Hosseinzadeh H.; Berberine protects against glutamate-induced oxidative stress and apoptosis in PC12 and N2a cells. Iran J Basic Med Sci  2017,20(5),594-603","journal-title":"Iran J Basic Med Sci"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.omtm.2018.03.001","volume":"9","author":"Falcicchia C.","year":"2018","unstructured":"Falcicchia C.; Paolone G.; Emerich D.F.; Lovisari F.; Bell W.J.; Fradet T.; Wahlberg L.U.; Simonato M.; Seizure-suppressant and neuroprotective effects of encapsulated BDNF-producing cells in a rat model of temporal lobe epilepsy. Mol Ther Methods Clin Dev  2018,9,211-224","journal-title":"Mol Ther Methods Clin Dev"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/brainsci13020163","volume":"13","author":"Gliwi\u0144ska A.","year":"2023","unstructured":"Gliwi\u0144ska A.; Czubili\u0144ska-\u0141ada J.; Wi\u0119ckiewicz G.; \u015awi\u0119tochowska E.; Bade\u0144ski A.; Dworak M.; Szczepa\u0144ska M.; The role of brain-derived neurotrophic factor (BDNF) in diagnosis and treatment of epilepsy, depression, schizophrenia, anorexia nervosa and alzheimer\u2019s disease as highly drug-resistant diseases: A narrative review. Brain Sci  2023,13(2),163","journal-title":"Brain Sci"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.npep.2018.09.005","volume":"72","author":"Iughetti L.","year":"2018","unstructured":"Iughetti L.; Lucaccioni L.; Fugetto F.; Predieri B.; Berardi A.; Ferrari F.; Brain-derived neurotrophic factor and epilepsy: A systematic review. Neuropeptides  2018,72,23-29","journal-title":"Neuropeptides"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1080\/19336950.2021.2002594","volume":"15","author":"Spiers J.G.","year":"2021","unstructured":"Spiers J.G.; Steinert J.R.; Nitrergic modulation of ion channel function in regulating neuronal excitability. Channels  2021,15(1),666-679","journal-title":"Channels"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"a022764","DOI":"10.1101\/cshperspect.a022764","volume":"6","author":"Khazipov R.","year":"2016","unstructured":"Khazipov R.; GABAergic synchronization in epilepsy. Cold Spring Harb Perspect Med  2016,6(2),a022764","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/jcb.25283","volume":"117","author":"Chen S.","year":"2016","unstructured":"Chen S.; Sang N.; Hypoxia-inducible factor-1: A critical player in the survival strategy of stressed cells. J Cell Biochem  2016,117(2),267-278","journal-title":"J Cell Biochem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1007\/s13577-022-00747-9","volume":"35","author":"Zalpoor H.","year":"2022","unstructured":"Zalpoor H.; Akbari A.; Nabi-Afjadi M.; Forghaniesfidvajani R.; Tavakol C.; Barzegar Z.; Iravanpour F.; Hosseini M.; Mousavi S.R.; Farrokhi M.R.; Hypoxia\u2010inducible factor 1 alpha (HIF\u20101\u03b1) stimulated and P2X7 receptor activated by COVID-19, as a potential therapeutic target and risk factor for epilepsy. Hum Cell  2022,35(5),1338-1345","journal-title":"Hum Cell"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/j.1528-1167.2012.03591.x","volume":"53","author":"Feast A.","year":"2012","unstructured":"Feast A.; Martinian L.; Liu J.; Catarino C.B.; Thom M.; Sisodiya S.M.; Investigation of hypoxia\u2010inducible factor\u20101\u03b1 in hippocampal sclerosis: A postmortem study. Epilepsia  2012,53(8),1349-1359","journal-title":"Epilepsia"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.brainres.2014.09.028","volume":"1590","author":"Long Q.","year":"2014","unstructured":"Long Q.; Fan C.; Kai W.; Luo Q.; Xin W.; Wang P.; Wang A.; Wang Z.; Han R.; Fei Z.; Qiu B.; Liu W.; Hypoxia inducible factor-1\u03b1 expression is associated with hippocampal apoptosis during epileptogenesis. Brain Res  2014,1590,20-30","journal-title":"Brain Res"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000438610","volume":"38","author":"Yang J.","year":"2016","unstructured":"Yang J.; He F.; Meng Q.; Sun Y.; Wang W.; Wang C.; Inhibiting HIF-1\u03b1 decreases expression of TNF-\u03b1 and caspase-3 in specific brain regions exposed kainic acid-induced status epilepticus. Cell Physiol Biochem  2016,38(1),75-82","journal-title":"Cell Physiol Biochem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"147281","DOI":"10.1016\/j.brainres.2021.147281","volume":"1757","author":"Kukec E.","year":"2021","unstructured":"Kukec E.; Gori\u010dar K.; Dol\u017ean V.; Rener-Primec Z.; HIF1A polymorphisms do not modify the risk of epilepsy nor cerebral palsy after neonatal hypoxic-ischemic encephalopathy. Brain Res  2021,1757,147281","journal-title":"Brain Res"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/ana.24147","volume":"75","author":"Bar-Klein G.","year":"2014","unstructured":"Bar-Klein G.; Cacheaux L.P.; Kamintsky L.; Prager O.; Weissberg I.; Schoknecht K.; Cheng P.; Kim S.Y.; Wood L.; Heinemann U.; Kaufer D.; Friedman A.; Losartan prevents acquired epilepsy via TGF\u2010\u03b2 signaling suppression. Ann Neurol  2014,75(6),864-875","journal-title":"Ann Neurol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"660","DOI":"10.4049\/jimmunol.181.1.660","volume":"181","author":"Qian L.","year":"2008","unstructured":"Qian L.; Wei S.J.; Zhang D.; Hu X.; Xu Z.; Wilson B.; El-Benna J.; Hong J.S.; Flood P.M.; Potent anti-inflammatory and neuroprotective effects of TGF-beta1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia. J Immunol  2008,181(1),660-668","journal-title":"J Immunol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.toxlet.2013.03.009","volume":"219","author":"Chitra P.","year":"2013","unstructured":"Chitra P.; Saiprasad G.; Manikandan R.; Sudhandiran G.; Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-\u03baB dependant TGF-\u03b2 activation: A biphasic experimental study. Toxicol Lett  2013,219(2),178-193","journal-title":"Toxicol Lett"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1007\/s43440-020-00143-w","volume":"72","author":"Borowicz-Reutt K.K.","year":"2020","unstructured":"Borowicz-Reutt K.K.; Czuczwar S.J.; Role of oxidative stress in epileptogenesis and potential implications for therapy. Pharmacol Rep  2020,72(5),1218-1226","journal-title":"Pharmacol Rep"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3390\/cells11050796","volume":"11","author":"Shou J.W.","year":"2022","unstructured":"Shou J.W.; Shaw P.C.; Therapeutic efficacies of berberine against neurological disorders: An update of pharmacological effects and mechanisms. Cells  2022,11(5),796","journal-title":"Cells"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/5080843","volume":"2019","author":"Su L.J.","year":"2019","unstructured":"Su L.J.; Zhang J.H.; Gomez H.; Murugan R.; Hong X.; Xu D.; Jiang F.; Peng Z.Y.; Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis. Oxid Med Cell Longev  2019,2019,1-13","journal-title":"Oxid Med Cell Longev"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.freeradbiomed.2009.07.035","volume":"47","author":"Kaspar J.W.","year":"2009","unstructured":"Kaspar J.W.; Niture S.K.; Jaiswal A.K.; Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med  2009,47(9),1304-1309","journal-title":"Free Radic Biol Med"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"18348","DOI":"10.3390\/ijms160818348","volume":"16","author":"Carmona-Aparicio L.","year":"2015","unstructured":"Carmona-Aparicio L.; P\u00e9rez-Cruz C.; Zavala-Tecuapetla C.; Granados-Rojas L.; Rivera-Espinosa L.; Montesinos-Correa H.; Hern\u00e1ndez-\nDami\u00e1n J.; Pedraza-Chaverri J.; Sampieri A., III; Coballase-Urrutia E.; C\u00e1rdenas-Rodr\u00edguez N.; Overview of Nrf2 as therapeutic target in epilepsy. Int J Mol Sci  2015,16(8),18348-18367","journal-title":"Int J Mol Sci"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1182\/blood-2002-07-2248","volume":"102","author":"Wagener F.A.D.T.G.","year":"2003","unstructured":"Wagener F.A.D.T.G.; van Beurden H.E.; von den Hoff J.W.; Adema G.J.; Figdor C.G.; The heme-heme oxygenase system: A molecular switch in wound healing. Blood  2003,102(2),521-528","journal-title":"Blood"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1046\/j.1365-2443.2003.00640.x","volume":"8","author":"Itoh K.","year":"2003","unstructured":"Itoh K.; Wakabayashi N.; Katoh Y.; Ishii T.; O\u2019Connor T.; Yamamoto M.; Keap1 regulates both cytoplasmic\u2010nuclear shuttling and degradation of Nrf2 in response to electrophiles. Genes Cells  2003,8(4),379-391","journal-title":"Genes Cells"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3390\/antiox9111029","volume":"9","author":"Lin T.K.","year":"2020","unstructured":"Lin T.K.; Chen S.D.; Lin K.J.; Chuang Y.C.; Seizure-induced oxidative stress in status epilepticus: Is antioxidant beneficial? Antioxidants  2020,9(11),1029","journal-title":"Antioxidants"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"a022699","DOI":"10.1101\/cshperspect.a022699","volume":"6","author":"Vezzani A.","year":"2016","unstructured":"Vezzani A.; Lang B.; Aronica E.; Immunity and inflammation in epilepsy. Cold Spring Harb Perspect Med  2016,6(2),a022699","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.3390\/children9101506","volume":"9","author":"Gakharia T.","year":"2022","unstructured":"Gakharia T.; Bakhtadze S.; Lim M.; Khachapuridze N.; Kapanadze N.; Alterations of plasma pro-inflammatory cytokine levels in children with refractory epilepsies. Children  2022,9(10),1506","journal-title":"Children"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3345\/kjp.2013.56.7.271","volume":"56","author":"Youn Y.","year":"2013","unstructured":"Youn Y.; Sung I.K.; Lee I.G.; The role of cytokines in seizures: Interleukin (IL)-1\u03b2, IL-1Ra, IL-8, and IL-10. Korean J Pediatr  2013,56(7),271-274","journal-title":"Korean J Pediatr"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"17151","DOI":"10.1073\/pnas.0806682105","volume":"105","author":"Riazi K.","year":"2008","unstructured":"Riazi K.; Galic M.A.; Kuzmiski J.B.; Ho W.; Sharkey K.A.; Pittman Q.J.; Microglial activation and TNF\u03b1 production mediate altered CNS excitability following peripheral inflammation. Proc Natl Acad Sci  2008,105(44),17151-17156","journal-title":"Proc Natl Acad Sci"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12974-019-1592-3","volume":"16","author":"Rawat C.","year":"2019","unstructured":"Rawat C.; Kukal S.; Dahiya U.R.; Kukreti R.; Cyclooxygenase-2 (COX-2) inhibitors: Future therapeutic strategies for epilepsy management. J Neuroinflammation  2019,16(1),197","journal-title":"J Neuroinflammation"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1002\/cphy.c130051","volume":"4","author":"Kenney M.J.","year":"2014","unstructured":"Kenney M.J.; Ganta C.K.; Autonomic nervous system and immune system interactions. Compr Physiol  2014,4(3),1177-1200","journal-title":"Compr Physiol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1021\/acsptsci.0c00040","volume":"3","author":"Li L.","year":"2020","unstructured":"Li L.; Yu Y.; Hou R.; Hao J.; Jiang J.; Inhibiting the PGE 2 receptor EP2 mitigates excitotoxicity and ischemic injury. ACS Pharmacol Transl Sci  2020,3(4),635-643","journal-title":"ACS Pharmacol Transl Sci"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.tox.2010.11.005","volume":"280","author":"Domitrovi\u0107 R.","year":"2011","unstructured":"Domitrovi\u0107 R.; Jakovac H.; Blagojevi\u0107 G.; Hepatoprotective activity of berberine is mediated by inhibition of TNF-\u03b1, COX-2, and iNOS expression in CCl4-intoxicated mice. Toxicology  2011,280(1-2),33-43","journal-title":"Toxicology"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"e15239","DOI":"10.14814\/phy2.15239","volume":"10","author":"Hayatdavoudi P.","year":"2022","unstructured":"Hayatdavoudi P.; Hosseini M.; Hajali V.; Hosseini A.; Rajabian A.; The role of astrocytes in epileptic disorders. Physiol Rep  2022,10(6),e15239","journal-title":"Physiol Rep"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.3390\/ijms21114096","volume":"21","author":"Sanz P.","year":"2020","unstructured":"Sanz P.; Garcia-Gimeno M.A.; Reactive glia inflammatory signaling pathways and epilepsy. Int J Mol Sci  2020,21(11),4096","journal-title":"Int J Mol Sci"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"851394","DOI":"10.3389\/fnins.2022.851394","volume":"16","author":"Cai M.","year":"2022","unstructured":"Cai M.; Lin W.; The function of NF-kappa B during epilepsy, a potential therapeutic target. Front Neurosci  2022,16,851394","journal-title":"Front Neurosci"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s13311-014-0259-0","volume":"11","author":"Staba R.J.","year":"2014","unstructured":"Staba R.J.; Stead M.; Worrell G.A.; Electrophysiological biomarkers of epilepsy. Neurotherapeutics  2014,11(2),334-346","journal-title":"Neurotherapeutics"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4103\/0972-2327.128649","volume":"17","author":"Bertram E.","year":"2014","unstructured":"Bertram E.; Electrophysiology in epilepsy surgery: Roles and limitations. Ann Indian Acad Neurol  2014,17(5),40","journal-title":"Ann Indian Acad Neurol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/142372","volume":"2012","author":"Mikkilineni S.","year":"2012","unstructured":"Mikkilineni S.; Cantuti-Castelvetri I.; Cahill C.M.; Balliedier A.; Greig N.H.; Rogers J.T.; The anticholinesterase phenserine and its enantiomer posiphen as 5'untranslated-region-directed translation blockers of the Parkinson\u2019s alpha synuclein expression. Parkinsons Dis  2012,2012,1-13","journal-title":"Parkinsons Dis"},{"key":"ref=79","doi-asserted-by":"publisher","DOI":"10.1177\/1559325819862449","volume":"17","author":"Zhou G.","year":"2019","unstructured":"Zhou G.; Yan M.; Guo G.; Tong N.; Ameliorative effect of berberine on neonatally induced type 2 diabetic neuropathy via modulation of BDNF, IGF-1, PPAR-\u03b3, and AMPK expressions. Dose Response  2019,17(3)","journal-title":"Dose Response"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"100703","DOI":"10.1016\/j.bbih.2023.100703","volume":"34","author":"Mittli D.","year":"2023","unstructured":"Mittli D.; Inflammatory processes in the prefrontal cortex induced by systemic immune challenge: Focusing on neurons. Brain Behav Immun Health  2023,34,100703","journal-title":"Brain Behav Immun Health"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.neurobiolaging.2012.10.017","volume":"34","author":"Chawla M.K.","year":"2013","unstructured":"Chawla M.K.; Penner M.R.; Olson K.M.; Sutherland V.L.; Mittelman-Smith M.A.; Barnes C.A.; Spatial behavior and seizure-induced changes in c-fos mRNA expression in young and old rats. Neurobiol Aging  2013,34(4),1184-1198","journal-title":"Neurobiol Aging"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.neuroscience.2004.11.031","volume":"131","author":"Baraban S.C.","year":"2005","unstructured":"Baraban S.C.; Taylor M.R.; Castro P.A.; Baier H.; Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression. Neuroscience  2005,131(3),759-768","journal-title":"Neuroscience"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"701575","DOI":"10.3389\/fphar.2021.701575","volume":"12","author":"Wang S.","year":"2021","unstructured":"Wang S.; Zhou L.; He C.; Wang D.; Cai X.; Yu Y.; Chen L.; Lu D.; Bian L.; Du S.; Wu Q.; Han Y.; The association between STX1B polymorphisms and treatment response in patients with epilepsy. Front Pharmacol  2021,12,701575","journal-title":"Front Pharmacol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"653887","DOI":"10.3389\/fphar.2021.653887","volume":"12","author":"Ye Y.","year":"2021","unstructured":"Ye Y.; Liu X.; Wu N.; Han Y.; Wang J.; Yu Y.; Chen Q.; Efficacy and safety of berberine alone for several metabolic disorders: A systematic review and meta-analysis of randomized clinical trials. Front Pharmacol  2021,12,653887","journal-title":"Front Pharmacol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12929-016-0290-z","volume":"23","author":"Chang C.F.","year":"2016","unstructured":"Chang C.F.; Lee Y.C.; Lee K.H.; Lin H.C.; Chen C.L.; Shen C.K.J.; Huang C.C.; Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS. J Biomed Sci  2016,23(1),72","journal-title":"J Biomed Sci"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fmolb.2018.00021","volume":"5","author":"Singh N.","year":"2018","unstructured":"Singh N.; Sharma B.; Toxicological effects of berberine and sanguinarine. Front Mol Biosci  2018,5,21","journal-title":"Front Mol Biosci"},{"key":"ref=87","first-page":"516","volume":"20","author":"Rad S.Z.K.","year":"2017","unstructured":"Rad S.Z.K.; Rameshrad M.; Hosseinzadeh H.; Toxicology effects of Berberis vulgaris (barberry) and its active constituent, berberine: A review. Iran J Basic Med Sci  2017,20(5),516-529","journal-title":"Iran J Basic Med Sci"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neulet.2010.09.038","volume":"486","author":"Kwon I.H.","year":"2010","unstructured":"Kwon I.H.; Choi H.S.; Shin K.S.; Lee B.K.; Lee C.K.; Hwang B.Y.; Lim S.C.; Lee M.K.; Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson\u2019s disease. Neurosci Lett  2010,486(1),29-33","journal-title":"Neurosci Lett"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"e107129","DOI":"10.1371\/journal.pone.0107129","volume":"9","author":"Kysenius K.","year":"2014","unstructured":"Kysenius K.; Brunello C.A.; Huttunen H.J.; Mitochondria and NMDA receptor-dependent toxicity of berberine sensitizes neurons to glutamate and rotenone injury. PLoS One  2014,9(9),e107129","journal-title":"PLoS One"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010283237240107121749","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/227219\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010283237240107121749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T06:32:51Z","timestamp":1728628371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/227219\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":89,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892010283237240107121749","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-09-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}